"The onus is on us as cardiologists to make sure we offer the very best possible devices for our patients with the available data that we have," interventional cardiologist Anene Ukaigwe, MD, explained.
Women with cardiovascular disease are consistently underdiagnosed and undertreated compared to men, and those disparities are true for aortic stenosis as well. Women with symptomatic severe AS are up to 35% less likely than men to undergo aortic valve replacement, for example, and they often have to wait longer just to be referred for further care.
The American Society of Nuclear Cardiology (ASNC) says positron emission tomography (PET) nuclear imaging has seen wider adoption in the past few years, and many cardiac imaging experts say it could become the workhorse technology for nuclear cardiac assessments over the next decade.
TAVR is a go-to treatment for symptomatic severe aortic stenosis in much of the world, thanks in large part to the hard work of research teams that never stop looking for new, innovative ways to make the technology more effective.
TAVR procedures have surged more than 30% since 2020, with more than 107,000 patients receiving a new prosthetic valve in 2023 alone. As this trend continues, it’s increasingly important that cardiologists consider the long-term impact on future coronary interventions patients may need.
This report offers a snapshot of what health system and cardiovascular leaders think. Some of it validates, while some enlightens. It all helps guide leadership on a data-rich and insightful journey into the future.
When it comes to CVIS strategy across the survey base, C-suite leaders and cardiovascular department heads share the responsibility equally often. But in academic medical centers and multi-hospital systems, the division of power is different.
Today CVIS sits at the heart of cardiovascular care, uniting and propelling clinical, operational and financial success. CVIS is the compass and brain guiding workflow, data flow, decision-making and driving good outcomes.
When we dig to unearth cardiovascular care’s top trends, challenges and goals, the findings bring the present into sharp relief: Today’s CV leaders are focused on growth and committed to improving both quality of care and operational performance. They also have their eyes on retaining talented staff and reducing clinician burnout.
The CV service line has big goals and is mapping out a route to reach them. Leaders are quite focused but know there are roadblocks and traffic jams in their way.
The Cardiovascular Business Leadership Survey shows healthcare organizations see cardiovascular image and information management systems as core to clinical and business functions essential for defining a data-rich path forward for more connected cardiology and better patient care.
When the cardiac and neurovascular catheterization lab at Riverside University Health System Medical Center (RUHS-MC) treated its first patient last February, the opening represented many things to many people.